Previous studies have shown PKCδ participates in HDAC inhibitor-induced differentiation of colon cancer and the resultant growth arrest and apoptosis in various cancers, but the mechanisms underlying this effect remains unclear [14, 17]. Here, PRKCD is linked to malignant colon neoplasm.